Amgen has announced a significant expansion of a manufacturing facility in the US state of Ohio, with an investment of $900m.

Amgen, based in Thousand Oaks, California, first broke ground in New Albany in 2021. Here's how the company plans to expand.

Amgen (NasdaqGS:AMGN) recently announced a significant $900 million expansion in its Ohio manufacturing facility, aiming to ...

Amgen Inc. will invest $900 million to expand an Ohio manufacturing facility, the latest drug company to promise increased US ...

After unveiling a new drug substance facility in North Carolina in December, Amgen is doubling down on expanding its U.S. | ...

NEW ALBANY, Ohio — Biotechnology company Amgen announced a $900 million expansion of its New Albany facility on Friday. The ...

Amgen will invest $900M to expand its Columbus region biomanufacturing facility, bringing total investment in Central Ohio to ...

Amgen on Friday announced a $900 million expansion of its Ohio biotech manufacturing facility, becoming the latest in a ...

Every week, reporter Jim Weiker rounds up the biggest business news of the week in his Breaking Ground newsletter. Check out his latest.

Analysts highlight MariTide's upcoming updates and near-term catalysts, while Amgen's price targets shift amid steady outlook ...